Yasuhiro Matsumura

Yasuhiro Matsumura's AcademicInfluence.com Rankings

Yasuhiro Matsumura

Physics

#3983

World Rank

#5548

Historical Rank

Cosmology

#109

World Rank

#115

Historical Rank

Astrophysics

#224

World Rank

#249

Historical Rank

physics Degrees

Download Badge

Physics

Yasuhiro Matsumura's Degrees

PhD Physics University of Tokyo
Masters Physics University of Tokyo
Bachelors Physics University of Tokyo

Why Is Yasuhiro Matsumura Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yasuhiro Matsumura's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. (1986) (6236)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. (2000) (5626)
Toxic effects of ultraviolet radiation on the skin. (2004) (1040)
Tumoritropic and lymphotropic principles of macromolecular drugs. (1989) (568)
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin (2004) (556)
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. (2003) (554)
Development of the polymer micelle carrier system for doxorubicin. (2001) (502)
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel (2005) (476)
Significance of CD44 gene products for cancer diagnosis and disease evaluation (1992) (473)
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles (2009) (456)
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats (2005) (379)
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours (2011) (336)
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. (2016) (291)
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer (2003) (266)
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation (2007) (260)
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. (2008) (245)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. (2004) (233)
Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. (2006) (220)
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer (2012) (208)
MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening (2010) (205)
Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. (2011) (187)
EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. (2011) (183)
Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. (1998) (174)
Exosome can prevent RNase from degrading microRNA in feces. (2011) (158)
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue (1988) (154)
Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine (2002) (146)
Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. (2008) (142)
Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors (2010) (139)
Development of polymeric micelles for targeting intractable cancers (2016) (126)
Molecular mechanisms of photocarcinogenesis. (2002) (124)
Polymeric micellar delivery systems in oncology. (2008) (116)
Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer. (1988) (114)
Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. (2015) (111)
Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines (1996) (108)
Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells (1994) (105)
Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil) (2002) (102)
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study (1991) (101)
NC‐6300, an epirubicin‐incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin (2013) (94)
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. (2006) (93)
The prolyl 4‐hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline‐deficient L‐amino acid‐defined diet (1996) (92)
Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities (1995) (91)
Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor Activity (2001) (90)
Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. (1996) (89)
Cancer stromal targeting (CAST) therapy. (2012) (88)
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel (2006) (79)
Low‐intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin (2008) (77)
Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. (1998) (77)
Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil (2003) (76)
Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test (2013) (73)
Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. (1998) (72)
New concept of cytotoxic immunoconjugate therapy targeting cancer‐induced fibrin clots (2011) (68)
Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin (1987) (67)
The drug discovery by nanomedicine and its clinical experience. (2014) (67)
Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. (1998) (67)
Potent antitumor effect of SN‐38‐incorporating polymeric micelle, NK012, against malignant glioma (2009) (67)
Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression. (2008) (66)
Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue. (2011) (66)
Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. (1995) (65)
A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. (2005) (65)
Antitumor effect of MCC‐465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts (2004) (63)
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. (1995) (61)
Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer (1998) (59)
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients (2010) (57)
Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. (2000) (57)
Role of Allergen Source-Derived Proteases in Sensitization via Airway Epithelial Cells (2012) (55)
Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. (1998) (55)
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences (2007) (54)
Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells. (1994) (54)
Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver. (1987) (53)
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. (2010) (53)
Synergistic antitumor activity of the novel SN‐38‐incorporating polymeric micelles, NK012, combined with 5‐fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5‐fluorouracil (2008) (53)
General considerations regarding the in vitro and in vivo properties of block copolymer micelle products and their evaluation. (2015) (52)
Reduction of the Side Effects of an Antitumor Agent, KRN5500, by Incorporation of the Drug into Polymeric Micelles (1999) (52)
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts (2015) (52)
Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. (1997) (51)
Targeting anticoagulant protein S to improve hemostasis in hemophilia. (2018) (51)
Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma (2000) (50)
Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. (2007) (47)
Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan (2003) (46)
Detection of colorectal cancer cells from feces using quantitative real‐time RT‐PCR for colorectal cancer diagnosis (2008) (46)
Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles. (2003) (46)
Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan. (2008) (46)
Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme. (2000) (45)
Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. (2000) (44)
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. (2011) (43)
Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review. (2005) (42)
Enhanced distribution of NK012, a polymeric micelle‐encapsulated SN‐38, and sustained release of SN‐38 within tumors can beat a hypovascular tumor (2008) (42)
Discovery of an uncovered region in fibrin clots and its clinical significance (2013) (41)
No prognostic significance of p53 expression in esophageal squamous cell carcinoma (1999) (40)
The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution (2013) (40)
Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine (1995) (40)
High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xeroderma pigmentosum patients. (1995) (40)
High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer (2016) (39)
Antitumor Effect of NK012, a 7-Ethyl-10-Hydroxycamptothecin–Incorporating Polymeric Micelle, on U87MG Orthotopic Glioblastoma in Mice Compared with Irinotecan Hydrochloride in Combination with Bevacizumab (2010) (38)
Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. (1993) (37)
Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles (2008) (37)
Inhibition of Tumor Necrosis Factor-α Production Retards Liver Regeneration after Partial Hepatectomy in Rats (1997) (36)
Antitumor Activity of NK012 Combined with Cisplatin against Small Cell Lung Cancer and Intestinal Mucosal Changes in Tumor-Bearing Mouse after Treatment (2009) (36)
Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene. (1997) (36)
Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase. (1991) (35)
Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles (2007) (35)
Effect of combined treatment with the epirubicin‐incorporating micelles (NC‐6300) and 1,2‐diaminocyclohexane platinum (II)‐incorporating micelles (NC‐4016) on a human gastric cancer model (2014) (35)
[General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics]. (1987) (34)
Cellular and hormonal mechanisms associated with malignant bone resorption. (1994) (33)
Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. (2005) (33)
CD44 Variant Isoform Expression and Breast Cancer Prognosis (1998) (33)
Influence of the dissociation rate constant on the intra‐tumor distribution of antibody‐drug conjugate against tissue factor (2018) (32)
Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer (2014) (32)
Characterization of p53 gene mutations in basal‐cell carcinomas: Comparison between sun‐exposed and less‐exposed skin areas (1996) (32)
Imaging mass spectrometry for the precise design of antibody-drug conjugates (2016) (30)
DNA fingerprinting survey of various human tumors and their metastases. (1992) (30)
Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour. (2010) (29)
Improvement of Pharmacological Properties of Protein-Drugs by Tailoring with Synthetic Polymers (1988) (29)
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients (2018) (29)
U3-1402, a Novel HER3-Targeting Antibody–Drug Conjugate, for the Treatment of Colorectal Cancer (2019) (29)
Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors. (2006) (28)
Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer. (2007) (28)
Close Association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 Haplotype and Its Apparent Influence on 7-Ethyl-10-hydroxycamptothecin (SN-38) Glucuronidation in Japanese (2009) (28)
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models (2015) (28)
Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. (2008) (27)
Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway (2018) (27)
Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targetability into Pancreatic Cancer Cells. (2018) (26)
Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity (2002) (26)
XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis. (2004) (26)
Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment (2016) (26)
Tailored immunoconjugate therapy depending on a quantity of tumor stroma (2013) (26)
Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy (1993) (25)
Detailed Distribution of NK012, an SN-38–Incorporating Micelle, in the Liver and Its Potent Antitumor Effects in Mice Bearing Liver Metastases (2010) (25)
Pharmacokinetic interactions between HIV‐protease inhibitors in rats (1999) (24)
The antitumor activity of NK012, an SN‐38–incorporating micelle, in combination with bevacizumab against lung cancer xenografts (2010) (24)
Neutrophilic panniculitis associated with myelodysplastic syndromes (1997) (24)
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease (2017) (23)
Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II. (2008) (23)
A New Tactic for the Treatment of Jaundice: An Injectable Polymer-Conjugated Bilirubin Oxidase (1988) (22)
Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese population. (2011) (22)
Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer (2001) (22)
Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody (2018) (22)
Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma (1998) (22)
Cytoprotection by glycine against hypoxia-induced injury in cultured hepatocytes. (2008) (22)
Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis. (2004) (21)
Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA. (1998) (21)
Phase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancer. (2006) (21)
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin (2018) (21)
Synergistic antitumor activity of the SN‐38‐incorporating polymeric micelles NK012 with S‐1 in a mouse model of non‐small cell lung cancer (2010) (21)
Development of localized gene delivery using a dual-intensity ultrasound system in the bladder. (2010) (21)
Cancer stromal targeting therapy to overcome the pitfall of EPR effect. (2020) (20)
Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging (2017) (20)
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors (2016) (19)
Characterization of Antibody Products Obtained through Enzymatic and Nonenzymatic Glycosylation Reactions with a Glycan Oxazoline and Preparation of a Homogeneous Antibody-Drug Conjugate via Fc N-Glycan. (2019) (19)
PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease (2004) (19)
Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety. (2008) (19)
Application of the fecal microRNA test to the residuum from the fecal occult blood test. (2013) (19)
Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis. (2010) (19)
Development of a diketopiperazine-forming dipeptidyl Gly-Pro spacer for preparation of an antibody–drug conjugate (2013) (18)
Recent advances in the study of tumour invasion and metastasis. (1994) (18)
CD44 and cancer (1993) (18)
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule (2019) (17)
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer. (2010) (17)
Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases (1999) (17)
Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model (2017) (17)
Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma (2000) (16)
New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces. (2008) (16)
Improved Recovery of Exfoliated Colonocytes from Feces Using Newly Developed Immunomagnetic Beads (2008) (16)
Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool. (2015) (15)
Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses. (2014) (14)
A case of cutaneous polyarteritis nodosa associated with ulcerative colitis (2000) (14)
Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection. (1987) (14)
Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. (2009) (14)
Enzymatic Removal of Bilirubin Toxicity by Bilirubin Oxidase In Vitro and Excretion of Degradation Products In Vivo (1990) (13)
Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene (1995) (13)
Fourteen novel genetic variations and haplotype structures of the TYMS gene encoding human thymidylate synthase (TS). (2006) (13)
[Micelle carrier system in clinical trial]. (2006) (13)
Heterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma (2010) (13)
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I. (2008) (13)
Cytotoxicity of bacterial proteases in various tumor cells mediated through alpha 2-macroglobulin receptor. (1989) (13)
The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline deficient L-amino acid-defined diet (1996) (13)
Utility of epirubicin‐incorporating micelles tagged with anti‐tissue factor antibody clone with no anticoagulant effect (2016) (13)
Long-term survivor of gastric small cell carcinoma. (2004) (12)
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trial. (2011) (12)
Enhanced Intestinal Absorption of a Hydrophobic Polymer-Conjugated Protein Drug, Smancs, in an Oily Formulation (1990) (12)
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus. (2020) (12)
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6. (2009) (12)
Serum level of octanoic acid predicts the efficacy of chemotherapy for colorectal cancer (2018) (12)
[Fecal Biomarker for Colorectal Cancer Diagnosis]. (2015) (12)
Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients. (2011) (11)
Deranged CD44 gene activity in malignancy (1993) (10)
Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer. (1999) (10)
Complete response achieved following administration of S-1 in a patient with adrenal gland metastasis of 5-FU-resistant gastric cancer: a case report. (2001) (10)
Topological analysis of TMEM180, a newly identified membrane protein that is highly expressed in colorectal cancer cells. (2019) (10)
Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis (2014) (10)
Inhibition of tumor necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats. (1997) (9)
New approaches for pancreatic cancer in Japan (2004) (9)
Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines (2016) (9)
Studies on relationships between metastatic and non-metastatic tumor cell populations using lineages labeled with dominant selectable genetic markers. (1993) (9)
New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA (2014) (9)
Phase I/II Study of NC-6004, A Novel Micellar Formulation of Cisplatin, In Combination with Gemcitabine in Patients with Pancreatic Cancer in Asia - Results of Phase I (2012) (9)
Clinicopathological significance of the expression of CD44v2 in colorectal cancer. (1999) (9)
Epidermolysis Bullosa Acquisita (EBA) with Nonclassical Distribution of Eruptions (1993) (9)
Inflammatory cellular phenotypes and molecular mechanisms of glucocorticoid resistance in patients with bronchial asthma. (2013) (9)
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5. (2009) (9)
Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) (2022) (9)
Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects. (2020) (9)
Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer. (2014) (8)
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07) (2021) (8)
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant (2012) (7)
Application of miRNA expression analysis on exfoliated colonocytes for diagnosis of colorectal cancer (2012) (7)
Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate (2021) (7)
Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy. (2021) (7)
Development of tissue factor-targeted liposomes for effective drug delivery to stroma-rich tumors. (2020) (7)
Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors. (2003) (7)
Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data. (2013) (7)
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method (2015) (7)
Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect (2014) (7)
Diagnostic application of CD44 variant expression in pancreatic juice for detection of pancreatic neoplasm. (2001) (6)
Barriers to antibody therapy in solid tumors, and their solutions (2021) (6)
Mosaic expression of uncein and 180‐kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa (1997) (6)
Inverse Relationship Between Increased Apoptosis and Decreased Skin Cancer in UV-irradiated CD1d−/− Mice¶ (2005) (6)
PCR-based assessment of the recovery rate of exfoliated colonocytes or cancer cells from fecal samples depends on the storage conditions after defecation. (2007) (6)
Gastrointestinal tumors, non-colorectal (2012) (6)
Detection of the DNA point mutation of colorectal cancer cells isolated from feces stored under different conditions. (2008) (6)
High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer (2021) (6)
Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening. (2014) (6)
Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patients. (2011) (6)
Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer. (2020) (5)
NOVEL SN-38-INCORPORATED POLYMERIC MICELLES, NK012, ERADICATE LUNG METASTASES AND INCREASE SURVIVAL IN THE MURINE RENAL CANCER MODEL (2008) (5)
35 years of discussions with Prof. Maeda on the EPR effect and future directions. (2022) (5)
[The prognostic factors of pancreatic cancer--adhesion molecule CD44]. (1998) (5)
Cancer Drug Delivery Systems Based on the Tumor Microenvironment (2019) (5)
A phase II study of NK012, a polymeric micelle formulation of SN-38, in colorectal cancer patients who had received prior oxaliplatin-based regimen. (2015) (5)
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models (2019) (5)
Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. (2019) (4)
Novel virtual cytological analysis for the detection of endometrial cancer cells using autoscan fluoromicroscopy (2011) (4)
Principle of CAST Strategy (2019) (4)
[Targeting of anticancer chemotherapy utilizing the characteristic nature of the neovasculature of solid tumors]. (1986) (4)
Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts. (2016) (4)
DNA polymorphism of obese people in Saku Control Obesity Program (SCOP) (2007) (4)
Fecal miR-106 a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test (2013) (4)
Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer. (2003) (4)
Expression of CD 44 variants and prognosis in oesophageal squamous cell carcinoma (1999) (3)
Clinical Cancer esearch cer Therapy : Clinical se I Study of NK 012 , a Novel SN-38 – Incorporating Micellar R oparticle , in Adult Patients with Solid Tumors (2010) (3)
423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer (2008) (3)
Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancer. (2002) (3)
Mass spectrometry imaging for early discovery and development of cancer drugs (2018) (3)
Quantification, isolation and structural determination of bradykinin and hydroxyprolyl-bradykinin in tumor ascites. (1989) (3)
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50) (2022) (3)
Tumor stromal barrier and cancer stromal targeting therapy (2013) (3)
Inflammation Induces Glucocorticoid Resistance in Patients with Bronchial Asthma (2009) (3)
Basic Aspects and Clinical Trials of Micelle Carrier System (2004) (2)
Antitumor activity of NK012 combined with cisplatin against small-cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment. (2009) (2)
Role of CD 44 Variant Exon 6 in Invasion of Head and Neck Squamous Cell Carcinoma (2000) (2)
Transcatheter therapy for liver metastasis from gastric cancer (2000) (2)
Optimum conditions of ultrasound-mediated destruction of bubble liposome for siRNA transfer in bladder cancer. (2010) (2)
Mechanism of Impairment in Wound Healing of Electron Beam-Irradiated Rat Skin (2005) (2)
Cancer and Blood Coagulation (2019) (2)
Usefulness of Immuno-Magnetic Beads Conjugated with Anti-EpCAM Antibody for Detecting Endometrial Cancer Cells (2013) (2)
The Synergistic Effect of Suplatast Tosilate and Tacrolimus Hydrate Ointment on the “Red Face” of Adult-type Atopic Dermatitis (2002) (2)
[Chemotherapy of urogenital cancers]. (1991) (2)
Abstract 1819: Fecal RNA test using microRNA expressions of exfoliated colonocytes for colorectal cancer screening (2011) (2)
Stabilization of an 211At-Labeled Antibody with Sodium Ascorbate (2021) (2)
Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: Analysis by HPLC (1990) (2)
A Novel and Potent Thrombolytic Fusion Protein Consisting of Anti-Insoluble Fibrin Antibody and Mutated Urokinase (2020) (2)
TGF-β inhibitor LY2157299 (galunisertib) in combination with standard chemotherapy and inhibition of signaling to pSmad and EMT and suppression of tumor growth in gastric cancer. (2016) (1)
Development of CAST therapy based on the EPR effect: lesson from clinical trials. (2018) (1)
312: Novel SN-38-Incorporated Polymeric Micelles, NK012, Eradicate Bulky Renal Tumors (2007) (1)
roRNA Expression Profiling of Exfoliated Colonocytes (2010) (1)
A clinical trial can determine the course of DDS development (2014) (1)
Chapter 7:Anticancer Agent-Incorporating Polymeric Micelles: from Bench to Bedside (2016) (1)
Clinical development of anticancer agents incorporating micelles in oncological treatment (2013) (1)
An interim analysis of phase I clinical trial of MCC-465, a doxorubicin (DXR) encapsulated in PEG-immunoliposome, in patients with metastatic stomach cancer. (2003) (1)
[Translational research of DDS based on polymeric micelles]. (2011) (1)
Abstract 2641: Tailored antibody drug conjugate (ADC) therapy depending on a quantity of tumor stroma (2014) (1)
Translational research of drug delivery system and the investigational new drug application for dds (2007) (1)
Commensal fungi are involved in antigen-specific antibody production in the elderly. (2015) (1)
Liposomes and micelles in cacner chemotherapy (2001) (1)
[A case of vesical carcinoma with sarcomatous changes--immunohistochemical and electron microscopic observations]. (1989) (1)
Prognostic Factors for Patients With Metastatic Colorectal Cancer Receiving Protracted Venous Infusion of 5-FU (2002) (1)
Blocking Protein S Improves Hemostasis in Hemophilia a and B (2016) (1)
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines (2021) (1)
Abstract 2648: Enhanced antitumor effect of anti tissue factor (TF) antibody-conjugated epirubicin-incorporating polymeric micelles in human cancer xenografts with high TF expression (2014) (1)
Cancer Stromal Targeting Therapy. (2017) (1)
Abstract 1669: Preclinical efficacy of Sym004, novel anti-EGFR antibody, in esophageal squamous cell carcinoma cell lines (2015) (1)
Peripheral blood mononuclear cell NF-kappaB p105 mRNA decreases during asthmatic attacks. (2008) (1)
A New Chemiluminescent Enzyme Immunoassay for Plasma Tissue FactorDetection (2014) (1)
The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3 (2021) (1)
A new colorectal cancer marker, TMEM180 and its preclinical antibody development. (2018) (1)
Development of ADCs Using Molecular Imaging. (2017) (1)
Cancer Stromal Targeting (CAST) Therapy and Tailored Antibody Drug Conjugate Therapy Depending on the Nature of Tumor Stroma (2013) (1)
Abstract 4917: High expression of miR-181c in tumor tissue as a recurrence marker of Dukes B colorectal cancer (2016) (1)
TMEM180 contributes to colorectal cancer proliferation through intracellular metabolic pathways (2020) (1)
Analysis ofAnomalous CD44GeneExpression inHumanBreast, Bladder, andColonCancer andCorrelation ofObserved mRNAandProtein Isoforms (1996) (0)
Abstract 2642: Antibody-drug conjugate for human pancreatic cancer cells using anti-tissue factor monoclonal antibody (2014) (0)
New tactics and basic mechanism of targeting chemotherapy in solid tumors (1989) (0)
Cancer Chemotherapy by DDS (2010) (0)
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin (2018) (0)
Analysis of mutations in p53 gene in basal cell epithelioma developed in sunexposed and non-sunexposed areas (1994) (0)
Clinical development of nano-dds (2011) (0)
Abstract 4849: Implications of cancer induced blood coagulation in cancer diagnosis and therapy (2014) (0)
Selection of Tumor models (2020) (0)
Mechanisms of Reduced Glucocorticoid Sensitivity in Bronchial Asthma (2012) (0)
29 Increase in radiation sensitivity by expression of wild-type p16 in human malignant melanoma cell lines (1996) (0)
Abstract 4012: Visualization of EPR effect and active targeting by using microscopic mass spectrometry (2017) (0)
Abstract 2855: Association between plasma tissue factor and tumor volume: A novel sensitive method for detecting plasma tissue factor (2014) (0)
A New Aspect of Drug Delivery System in Cancer Therapy (2010) (0)
The initiatives for regulatory science researches of nanomedicines (2014) (0)
Intake of Vitamin E Supplements by Members of the Japanese Society of Nutrition and Dietetics (2008) (0)
Abstract LB-11: Reduced cardiotoxicity and improved antitumor effect of the epirubicin-incorporating micelle NC-6300 in a hepatocellular carcinoma model (2012) (0)
Synergistic antitumor activity of novel polymeric micelles incorporating SN-38 (NK012) in combination with 5-fluorouracil (5-FU) in mouse model of colon cancer (2007) (0)
Visualisation of drug delivery by using high resolution microscopic mass spectrometry (2014) (0)
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant (2012) (0)
Topological analysis of TMEM180, a newly identified membrane protein that is highly expressed in colorectal cancer cells (2019) (0)
Clinical Cancer esearch cer Therapy : Preclinical ailed Distribution of NK 012 , an SN-38 – Incorporating elle , in the Liver and Its Potent Antitumor Effects R ice Bearing Liver Metastases (2010) (0)
Abstract 139: M2698, a novel dual inhibitor of p70S6K and Akt: preclinical efficacy in gastric cancer (2017) (0)
Abstract 2863: Preclinical evaluation of astatine-211-conjugated anti-tissue factor antibody (2020) (0)
Cancer stromal targeting (2013) (0)
Contribution from Synthetic Organic Chemistry and Glycoscience to ADC Development: Homogeneous ADC Preparation and Development of Cancer Stromal Targeting Therapy (2020) (0)
Abstract 2935: Preclinical efficacy of the p70S6K/AKT dual inhibitor M2698 in combination with trastuzumab in models of gastric cancer (2018) (0)
CD44: A recent trend (1997) (0)
[OPINION]Direction for development of DDS in oncology (2019) (0)
Abstract 2137: Development of CAST (cancer stromal targeting) therapy. (2013) (0)
[OPINION] Clinical significance of DDS (2015) (0)
有機合成化学/糖質化学は抗体-薬物複合体開発にどのように貢献できるか：糖鎖連結均一抗体-薬物複合体合成とがん間質ターゲティング療法の開拓 (2020) (0)
Significant antitumour effect of an antibody against TMEM180, a new cancer-specific molecule (2018) (0)
Development of local gene therapy using ultrasound and bubble-liposomes in orthotopic models for superficial bladder cancer (2008) (0)
NK012, a polymeric micelle formulation containing SN-38, markedly enhanced the antitumor activity of SN-38 against orthotopic glioblastoma multiforme tumors in a mouse model (2008) (0)
[Multidisciplinary therapy of urogenital cancer]. (1985) (0)
Clinical applications of monoclonal antibody therapy. (2001) (0)
The Current Status of Cancer Drug Delivery Systems and Future Directions (2019) (0)
Abstract LB-433: A new method of colorectal cancer screening using microRNA expression profiles of colonocytes isolated from feces (2010) (0)
DDS in development of anticancer agent (2005) (0)
Commentary: Clinical Trials Represent the Best Cancer Care. Or Do They? (2011) (0)
Use of a trypsin inhibitor of soybean kunitztyps and its derivatives for the preparation of medicaments containing the same and agens. (1987) (0)
Abstract 5292: Multitarget fecal miRNA test combined with fecal occult blood test and fecal miRNA test for colorectal cancer screening (2017) (0)
Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): 29-month (mo) follow-up from CheckMate 648. (2023) (0)
Thinking about The Japan Society of DDS (2020) (0)
027 Characterization of molecular defects in xeroderma pigmentosum group F (1997) (0)
Role of Microbiota in Atopic Dermatitis and Bronchial Asthma - Triangular Cross-Talk among Skin, Airway and Gut (2020) (0)
Preclinical Studies of ADC Therapy for Solid Tumors (2019) (0)
Recent Topics in Steroid and Asthma: Beyond the 'Classic' Concept of Action (2015) (0)
Drug delivery system in cancer chemotherapy (2003) (0)
Interferon gamma treatment inhibits collagen deposition in pig serum-induced rat liver fibrosis in vivo (1995) (0)
Mutation Specificity and Cancer (1997) (0)
A case of mycosis fungoides which invased to esophageal mucous membrane and intra oral mucosa. (1994) (0)
Potent antitumor effect of NK012 (polymeric micelles incorporating SN-38) against hepatic metastases in a model of colorectal cancer (2010) (0)
Clinical and pathobiological heterogeneity of asthma—Mechanisms of severe and glucocorticoid-resistant asthma (2013) (0)
Dietary or Supplementary Intake Modulates Inflammatory Response in Asthma Response in Asthma (2015) (0)
Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe (2016) (0)
TMEM180 contributes to SW480 human colorectal cancer cell proliferation through intra-cellular metabolic pathways (2021) (0)
Title : Application of the fecal micro RNA test to the residuum from the fecal occult blood test (2015) (0)
Abstract 3784: The role of the taurine transporter SLC6A6 in promoting prosurvival activity and multidrug resistance of colorectal cancer (2016) (0)
Biotechnology in Skin Care (V): UV and Sun Protection (2006) (0)
Clinical trial of MCC-465, a doxorubicin encapsulated in PEG-immunoliposome, in patients with metastatic stomach cancer (2004) (0)
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method (2015) (0)
ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL (2019) (0)
Abstract 4760: Discovery of novel biomarkers against refractory cancer usingin situlevel mass spectrometry informatics (2020) (0)
MicroRNA analysis of colorectal cancer using fecal and tissue samples (2017) (0)
Characterization of antibody clones that bind exclusively to insoluble fibrin (2022) (0)
Abstract 1784: IL-7R targeting therapy for immunoregulation and overcoming steroid resistance in cancer and autoimmune disease (2018) (0)
Abstract 220: U3-1402, a novel HER3-targeting ADC, inhibits the tumor growth of colorectal cancer xenografts (2019) (0)
Importance of enhanced distribution of NK012 and long-term, sustained-release of SN-38 for the treatment of hypovascular tumors (2008) (0)
Guideline for clinical safety data management in Japan Clinical Oncology Group (JCOG) (version 4) (2001) (0)
Preclinical studies of immunomicelles incorporating anticancer drugs (2019) (0)
Mutations in p53 gene and their clinical implication in epithelial skin cancer (1997) (0)
A study of twenty-nine early gastric cancers (1969) (0)
New prolyl 4-hydroxylase inhibitor inhibits pig serum-induced liver fibrosis by preventing ITO cell activation (1995) (0)
Abstract 1645: Characterization of a novel anti-insoluble-fibrin chimeric antibody (AFCA) for cancer stromal target (CAST) therapy and diagnosis. (2013) (0)
Mutation and overexpression of p53 gene in human skin cancer of sun-exposed area (1993) (0)
Abstract 2062: The biodistribution pattern depending on the size of anti-tissue factor antibodies (2014) (0)
Pharmacokinetics of NC-6004, a novel micellar formulation of cisplatin, in a Phase I trial (2008) (0)
A Case of Cutaneous Malignant Melanoma on Right Zygomatic Region on which Sentinel Node Biopsy was Performed (2002) (0)
A case of malignant melanoma with spontaneous regression of the primary lesion. (2000) (0)
F8-7 Mechanism of ito cell activation in rat liver cirhosis induced by a choline-deficient (CD) diet and prevention of ito cell activation by prolyl 4-hydroxylase inhibitor (1995) (0)
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease (2017) (0)
Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model (2017) (0)
Latest Research 8 A new attraction of sea food : Taurine deficiency creates a vicious cycle promoting obesity (2006) (0)
Abstract 4602: The dissociation constant rate of ADC would be an important factor for antitumor activityin vivo (2017) (0)
Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1. (2010) (0)
Abstract 203: Visualization of drug delivery by using high resolution microscopic mass spectrometry (2015) (0)
Development of a specific targeting system for pancreatic tumors utilizing antibody conjugated Pt-loaded micelles (2014) (0)
Blow a new wind towards The Japan Society of Drug Delivery System (2019) (0)
A Patient with Chronic Leg Ulcer Sensitized by Lanolin and Parabens (2002) (0)
The 30th anniversary of the first appearance of the EPR effect (2017) (0)
DDS IN CANCER CHEMOTHERAPY Clinical Study of Adriamycin Encapsulated PEG-immunoliposome and Development of Micelles Incorporated KRN5500 (2001) (0)
Abstract 2274: Development of bispecific antibodies using molecular imaging (2020) (0)
High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer (2021) (0)
Recentadvances inthestudyoftumour invasion andmetastasis (1994) (0)
Abstract 2674: Preparation and characterization of scFv antibody against tissue factor (TF) for the delivery of an MRI contrast agent. (2013) (0)
Abstract 1491: Tissue miRNA as a predictive marker for recurrence of Dukes B colorectal cancer (2014) (0)
Microscopic Mass Spectrometry for the Precise Design of Drug Delivery Systems (2016) (0)
Expression of XPF/ERCC4 and ERCC1 in Normal Human and Group F Xeroderma Pigmentosum Cells. (1996) (0)
Incorporation of water-insoluble drug into polymeric micelle: Control of incorporation efficiency and micelle size (1998) (0)
Clinical significance of DDS (2015) (0)
Anticancer agent-incorporating immunomicelles (2015) (0)
Non-invasive detection ofbladder cancerby identification ofabnormal CD44proteins in exfoliated cancercells inurine (1995) (0)
Isolation andcharacterisation ofantibodies whichspecifically recognise thepeptide encoded byexon7(v2) ofthehumanCD44gene (1995) (0)
' s response to reviews Title : Construction of possible integrated predictive index based on EGFR and ANXA 3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method (2015) (0)
The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats (1995) (0)
Association of a novel polymorphism G-133C of thymidylate synthase (TYMS) gene with 5-FU-related severe diarrhea in Japanese patients with colorectal cancer (2007) (0)
Inverse Relationship Between Increased Apoptosis and Decreased Skin Cancer in UV‐irradiated CD1d‐/‐ Mice ¶ (2005) (0)
REPAIR OF OXIDATIVE DNA DAMAGE IN UVB HYPERSENSITIVE DISORDERS (2000) (0)
Role of Protein S and Gas6 in the Development of Purpura Fulminans (2015) (0)
Abstract 4525: Combined antitumor activity of the epirubicin-incorporating polymeric micelle NC-6300 and the DACHPt-incorporating polymeric micelle NC-4016 in mice bearing human gastric cancer xenografts. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yasuhiro Matsumura?

Yasuhiro Matsumura is affiliated with the following schools:

Yasuhiro Matsumura's Academic­Influence.com Rankings

Yasuhiro Matsumura's Degrees

Why Is Yasuhiro Matsumura Influential?

Yasuhiro Matsumura's Published Works

Published Works

What Schools Are Affiliated With Yasuhiro Matsumura?

Yasuhiro Matsumura's AcademicInfluence.com Rankings